持续质量改进项目对慢性肾脏病门诊患者对比剂肾病的影响:一项中断时间序列研究
该多中心前瞻性中断时间序列研究(2006—2018年)评估对比剂肾病质量改进(CIN-QI)项目在慢性肾脏病门诊患者中的效果。项目基于缩短的生理盐水水化方案并设置自动病历提醒,结果预防性水化率、随访肾功能检测率均提高,CIN发生率显著下降,晚期CKD患者对比增强CT订单数呈负向趋势变化。
要点
- CIN-QI项目实施后预防性水化率由2.0%—23.2%升至59.2%—75.2%(P < .001)。
- 随访肾功能检测率由18.6%—25.8%升至34.1%—42.5%(P < .001)。
- CIN发生率在项目启动时水平下降10.0%(P = .002),趋势每年下降2.9%(P < .001)。
核心结论
- CIN-QI项目的多层面干预可能与CIN发生率降低及预防性水化和随访肾功能检测率提高相关。
研究设计与样本
- 多中心前瞻性中断时间序列研究,2006年至2018年开展,纳入95 594例接受对比增强CT的患者。
- 干预为基于缩短的生理盐水水化方案的CIN-QI项目,并设置自动病历系统提醒,在eGFR <45 mL/min/1.73 m2的患者开具对比增强影像时指示医生咨询肾内科医生并给予预防性水化和随访。
主要发现
- 年度预防性水化率在CIN-QI项目前为2.0%—23.2%,项目期间增至59.2%—75.2%(P < .001)。
- 年度随访肾功能检测率在项目实施后由18.6%—25.8%升至34.1%—42.5%(P < .001)。
- CIN发生率在CIN-QI项目启动时水平下降10.0%(P = .002),趋势每年下降2.9%(P < .001)。
- 在eGFR <45 mL/min/1.73 m2的晚期CKD目标患者中,CIN-QI项目实施启动时对比增强CT订单数呈正向水平变化。
- 项目实施后,所有患者的对比增强CT订单数呈负向趋势变化,晚期CKD患者从每年-1.4%降至每年-10.0%。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Contrast-induced nephropathy (CIN) caused by exposure to radioactive contrast media can cause acute kidney injury in patients with chronic kidney disease (CKD). We developed a multifaceted approach in a CIN-quality improvement (QI) program based on a shorter saline hydration protocol for the prevention of CIN in outpatients and assessed the effect of our CIN-QI program on decreasing both the incidence rate of CIN and overall use of contrast agents in patients undergoing contrast-enhanced computed tomography (CT). METHODS: We conducted a multi-center prospective interrupted time-series study from 2006 to 2018 investigating the efficacy of a CIN-QI program in preventing CIN among outpatients with CKD. An automatic medical record system alert was implemented to instruct physicians to consult a nephrologist and administer prophylactic hydration and follow-up when ordering contrast-enhanced imaging in patients with an estimated glomerular filtration rate (eGFR) <45 mL/min/1.73 m2. The primary outcomes were the rates of prophylactic hydration and follow-up kidney function assessment, and the incidence of CIN for eligible patients. The usage rate of contrast-enhanced CT was also examined. RESULTS: A total of 95 594 patients who underwent contrast-enhanced CT were included in the study. The annual prophylactic hydration rate before the CIN-QI program ranged from 2.0% to 23.2% but increased to 59.2%-75.2% during the CIN-QI program (P < .001). The annual rate of follow-up kidney function testing also improved from 18.6%-25.8% to 34.1%-42.5% after implementation of the CIN-QI program (P < .001). The rate of CIN significantly declined in level by 10.0% at the start of the CIN-QI program (P = .002) and in trend by 2.9%/year (P < .001). The number of contrast-enhanced CT orders showed a positive level change in patients with advanced CKD, who were the CIN-QI program target group of patients with eGFR <45 mL/min/1.73 m2, at the start of the implementation of the CIN-QI program. After implementing the CIN-QI program, the number of contrast-enhanced CT orders showed a negative trend change across all patients, which decreased from -1.4%/year to -10.0%/year for patients with advanced CKD. CONCLUSION: The multifaceted approach in the CIN-QI program may be associated with the decreased incidence of CIN and increased rates of prophylactic hydration and follow-up kidney function testing.
引用
- Hirano K, Kobayashi D, Shimbo T, et al. Impact of a continuous quality improvement program on contrast-induced nephropathy in outpatients with chronic kidney disease: an interrupted time-series study. Nephrol Dial Transplant. 2023. PMID: 36099912. doi:10.1093/ndt/gfac268
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。